Sort by
Refine Your Search
-
Listed
-
Field
-
Summary The lab is seeking a skilled scientist with expertise in immunology, genome engineering, and synthetic biology to join our cutting-edge laboratory focused on developing potent CAR/TCR-T cell
-
required. Preferred Qualifications Ph.D. in immunology, genetic engineering or related fields. Great fund of knowledge of tumor immunology principles. Able to assess scRNAseq datasets and highly parametric
-
advanced technology cores, animal facilities, and high-performance computational resources to conduct their experiments. Houston is among the most diverse cities in the country, with many cultural amenities
-
engineered voltage indicators. The St-Pierre lab aims to design, characterize, and deploy protein tools to accelerate neuroscience research and broader applications, with a particular emphasis on developing
-
of rare disease funded by the National Human Genome Research Institute (NHGRI) and as a sequence technology core for the Texas Medical Center Genomic Center for Infectious Disease (GCID) established by
-
of neurodevelopmental and neuropsychiatric conditions using cutting-edge proximity proteomics, protein engineering, CRISPR genome engineering, computational structural biology, and high-throughput electrophysiological
-
engineered mouse models (GEMMs). We are actively seeking a highly motivated Postdoctoral Associate who shares our passion for translational tumor research. For further insight into our work, please consider
-
cancer and their survival, development of improved technology to identity extracellular platelet phosphatase in the tumor microenvironment and large-scale analysis and validation of platelet phosphatase in
-
the immune response to lung cancer and their survival, development of improved technology to identity extracellular platelet phosphatase in the tumor microenvironment and large-scale analysis and validation
-
Gregor Consortium to elucidate the genetics of rare disease funded by the National Human Genome Research Institute (NHGRI) and as a sequence technology core for the Texas Medical Center Genomic Center